VELDHOVEN, the Netherlands - ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program.
| Date | Total repurchased shares | Weighted average price | Total repurchased value |
| 16-Apr-18 | 27,009 | 167.76 | 4,530,967.45 |
| 17-Apr-18 | - | - | - |
| 18-Apr-18 | - | - | - |
| 19-Apr-18 | 29,000 | 164.17 | 4,761,043.94 |
| 20-Apr-18 | 30,020 | 158.59 | 4,760,754.24 |
ASML's current share buyback program was announced on 17 January 2018, and details are available on our website at https://www.asml.com/investors/share-buyback/en/s25436
This regular update of the transactions conducted under the buyback program is to be made public under the Market Abuse Regulation (Nr. 596/2014).
| Media Relations Contacts | Investor Relations Contacts |
| Monique Mols, phone +31 6 528 444 18 | Skip Miller, phone +1 480 235 0934 |
| Niclas Mika, phone +31 6 201 528 63 | Marcel Kemp, phone +31 40 268 6494 |


Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 



